|
1
|
Kang GH, Shim YH, Jung HY, Kim WH, Ro JY
and Rhyu MG: CpG island methylation in premalignant stages of
gastric carcinoma. Cancer Res. 61:2847–2851. 2001.PubMed/NCBI
|
|
2
|
Bernal C, Aguayo F, Villarroel C, et al:
Reprimo as a potential biomarker for early detection in gastric
cancer. Clin Cancer Res. 14:6264–6269. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ksiaa F, Ziadi S, Amara K, Korbi S and
Trimeche M: Biological significance of promoter hypermethylation of
tumor-related genes in patients with gastric carcinoma. Clin Chem
Acta. 404:128–133. 2009. View Article : Google Scholar
|
|
4
|
Lerman MI and Minna JD: The 630-kb lung
cancer homozygous deletion region on human chromosome 3p21.3:
identification and evaluation of the resident candidate tumor
suppressor genes. The international lung cancer chromosome 3p213
tumor suppressor gene consortium. Cancer Res. 60:6116–6133.
2000.PubMed/NCBI
|
|
5
|
Hesson LB, Cooper WN and Latif F:
Evaluation of the 3p21.3 tumour-suppressor gene cluster. Oncogene.
26:7283–7301. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qu Y, Dang S and Hou P: Gene methylation
in gastric cancer. Clinica Chim Acta. 424:53–65. 2013. View Article : Google Scholar
|
|
7
|
van der Weyden L and Adams DJ: The
Ras-association domain family (RASSF) members and their role in
human tumourigenesis. Biochim Biophys Acta. 1776:58–85.
2007.PubMed/NCBI
|
|
8
|
Baksh S, Tommasi S, Fenton S, et al: The
tumor suppressor RASSF1A and MAP-1 link death receptor signaling to
Bax conformational change and cell death. Mol Cell. 18:637–650.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ahmed-Choudhury J, Agathanggelou A, Fenton
SL, et al: Transcriptional regulation of cyclin A2 by RASSF1A
through the enhanced binding of p120E4F to the cyclin A2 promoter.
Cancer Res. 65:2690–2697. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Korah R, Healy JM, Kunstman JW, et al:
Epigenetic silencing of RASSF1A deregulates cytoskeleton and
promotes malignant behavior of adrenocortical carcinoma. Mol
Cancer. 12:872013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Palakurthy RK, Wajapeyee N, Santra MK, et
al: Epigenetic silencing of the RASSF1A tumor suppressor gene
through HOXB3-mediated induction of DNMT3B expression. Mol Cell.
36:219–230. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kang GH, Lee S, Kim JS and Jung HY:
Profile of aberrant CpG island methylation along the multistep
pathway of gastric carcinogenesis. Lab Invest. 83:635–641. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zou XP, Zhang B, Zhang XQ, Chen M, Cao J
and Liu WJ: Promoter hypermethylation of multiple genes in early
gastric adenocarcinoma and precancerous lesions. Hum Pathol.
40:1534–1542. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ye M, Xia B, Guo Q, Zhou F and Zhang X:
Association of diminished expression of RASSF1A with promoter
methylation in primary gastric cancer from patients of central
China. BMC Cancer. 7:1202007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou SL, Cui J, Fan ZM, et al:
Polymorphism of A133S and promoter hypermethylation in Ras
association domain family 1A gene (RASSF1A) is associated with risk
of esophageal and gastric cardia cancers in Chinese population from
high incidence area in northern China. BMC Cancer. 13:2592013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo W, Dong Z, Chen Z, et al: Aberrant CpG
island hypermethylation of RASSF1A in gastric cardia
adenocarcinoma. Cancer Invest. 27:459–465. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Deng ZH, Wen JF, Li JH, Xiao DS and Zhou
JH: Activator protein-1 involved in growth inhibition by RASSF1A
gene in the human gastric carcinoma cell line SGC7901. World J
Gastroenterol. 14:1437–1443. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Feng Y, Zhang S and Huang X: A robust
TALENs system for highly efficient mammalian genome editing. Sci
Rep. 4:36322014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rivera MN, Kim WJ, Wells J, et al: The
tumor suppressor WTX shuttles to the nucleus and modulates WT1
activity. Proc Natl Acad Sci USA. 106:8338–8343. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang Z, Lee H, Lee E, Kang SK, Nam JM and
Lee M: Responsive nematic gels from the self-assembly of aqueous
nanofibres. Nat Commun. 2:4592011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kitagawa M, Higashi H, Jung HK, et al: The
consensus motif for phosphorylation by cyclin D1-Cdk4 is different
from that for phosphorylation by cyclin A/E-Cdk2. EMBO J.
15:7060–7069. 1996.PubMed/NCBI
|
|
22
|
To KF, Leung WK, Lee TL, et al: Promoter
hypermethylation of tumor-related genes in gastric intestinal
metaplasia of patients with and without gastric cancer. Int J
Cancer. 102:623–628. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu B, El Hajj N, Sittler S, Lammert N,
Barnes R and Meloni-Ehrig A: Gastric cancer: Classification,
histology and application of molecular pathology. J Gastrointes
Oncol. 3:251–261. 2012.
|
|
24
|
Byun DS, Lee MG, Chae KS, Ryu BG and Chi
SG: Frequent epigenetic inactivation of RASSF1A by aberrant
promoter hypermethylation in human gastric adenocarcinoma. Cancer
Res. 61:7034–7038. 2001.PubMed/NCBI
|
|
25
|
Reu FJ, Leaman DW, Maitra RR, et al:
Expression of RASSF1A, an epigenetically silenced tumor suppressor,
overcomes resistance to apoptosis induction by interferons. Cancer
Res. 66:2785–2793. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jung Y, Park J, Kim TY, et al: Potential
advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition
for cancer therapy. J Mol Med (Berl). 85:1137–1148. 2007.
View Article : Google Scholar
|
|
27
|
Shen WJ, Dai DQ, Teng Y and Liu HB:
Regulation of demethylation and re-expression of RASSF1A gene in
gastric cancer cell lines by combined treatment of 5-Aza-CdR and
NaB. World J Gastroenterol. 14:595–600. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Agathanggelou A, Cooper WN and Latif F:
Role of the Ras-association domain family 1 tumor suppressor gene
in human cancers. Cancer Res. 65:3497–3508. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shivakumar L, Minna J, Sakamaki T, Pestell
R and White MA: The RASSF1A tumor suppressor blocks cell cycle
progression and inhibits cyclin D1 accumulation. Mol Cellular Biol.
22:4309–4318. 2002. View Article : Google Scholar
|
|
30
|
Agathanggelou A, Bieche I, Ahmed-Choudhury
J, et al: Identification of novel gene expression targets for the
Ras association domain family 1 (RASSF1A) tumor suppressor gene in
non-small cell lung cancer and neuroblastoma. Cancer Res.
63:5344–5351. 2003.PubMed/NCBI
|
|
31
|
Arteaga CL: Cdk inhibitor p27Kip1 and
hormone dependence in breast cancer. Clin Cancer Res. 10:368S–371S.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shin JY, Kim HS, Park J, Park JB and Lee
JY: Mechanism for inactivation of the KIP family cyclin-dependent
kinase inhibitor genes in gastric cancer cells. Cancer Res.
60:262–265. 2000.PubMed/NCBI
|
|
33
|
Xiong H, Chen ZF, Liang QC, et al:
Inhibition of DNA methyltransferase induces G2 cell cycle arrest
and apoptosis in human colorectal cancer cells via inhibition of
JAK2/STAT3/STAT5 signalling. J Cell Mol Med. 13:3668–3679. 2009.
View Article : Google Scholar
|
|
34
|
Sun Y, Deng D, You WC, et al: Methylation
of p16 CpG islands associated with malignant transformation of
gastric dysplasia in a population-based study. Clin Cancer Res.
10:5087–5093. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu J, Xie YS, Wang FL, Zhang LJ, Zhang Y
and Luo HS: Cytotoxicity of 5-Aza-2′-deoxycytidine against gastric
cancer involves DNA damage in an ATM-P53 dependent signaling
pathway and demethylation of P16 (INK4A). Biomed Pharmacother.
67:78–87. 2013. View Article : Google Scholar
|
